Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVOCAR-1
2018-001234-18Phase 4Unknown
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Dec 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of evolocumab in carotid atheroma (CAS), sponsored by Imperial College Healthcare NHS Trust. Primary endpoint: Change in lipid-rich necrotic core size at 12 months. Status: unknown.
02
Drugs
evolocumab
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on 2018-001234-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001234-18.